Influence of Vocal Aging and Visual Cues on Listener Perception of Speaker Age

Date Added
November 14th, 2025
PRO Number
Pro00147043
Researcher
Cali Loblundo

List of Studies

Keywords
Aging, Healthy Volunteer Studies, Throat
Summary

This cross-sectional study aims to examine the impact of visual cues on listeners' perception of speaker age. Eligible speaking participants include adult males and females between the ages of 18–90 years old without voice or hearing disorders. Eligibility will be determined by research coordinators via patient demographic forms and validated voice and hearing assessments. Speaking participants will have two audio recordings taken: (1) sustained vowel sound and (2) reading of the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V), a standardized tool employed to evaluate the perceptual characteristics of voice quality across a wide age range. To develop the materials for the listening participants, CAPE-V audio recordings obtained from the speaking participants will be systematically paired with race and age-matched photographs obtained from a publicly available database. The finalized materials will encompass three experimental conditions: (1) audio only, (2) audio presented with a standardized photograph of an individual matched to the speaker's gender and age, and (3) audio presented with a standardized photograph of an individual matched for gender but differing in age. Naïve listening participants, blinded to the experimental conditions, will then be presented with these materials in a randomized order and asked to estimate the perceived ages of the speakers. Additionally, basic acoustic analyses of each sustained vowel sound recording (e.g., jitter, shimmer) will be conducted by a trained professional using the speech analysis software PRAAT.

Institution
MUSC
Recruitment Contact
Priyanka Shah
571-439-4745
shahpri@musc.edu

A Randomized Phase II Study of Nivolumab versus Nivolumab and BMS-986016 (Relatimab) as Maintenance Treatment after First-line Treatment with Platinum-Gemcitabine-Nivolumab for Patients with Epstein-Barr Virus- Associated Recurrent/Metastatic Nasopharyngeal Carcinoma (REMAIN)

Date Added
November 14th, 2025
PRO Number
Pro00146870
Researcher
John Kaczmar

List of Studies


Keywords
Cancer, Drug Studies, Men's Health, Women's Health
Summary

This study is for subjects who have been diagnosed with recurrent or metastatic nasopharyngeal cancer. Subjects are expected to remain in the study for a minimum of 70 months. Drugs are FDA approved and is given through a vein (also called IV or intravenous). The procedures include blood and urine tests, troponin test. Risks include infection, bruising, bleeding, anemia, kidney damage, hearing loss, nausea, vomiting, numbness, pain, rash, blood in urine. You may not receive a benefit from participating in this trial, however, information learned from the trial may help other people in the future.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
843-792-9321
hcc-clinical-trials@musc.edu

Preliminary development of a digitally enhanced decisional aid for peripartum cannabis use

Date Added
November 14th, 2025
PRO Number
Pro00145803
Researcher
Marie Hayes

List of Studies

Keywords
Pregnancy
Summary

We will develop a prototype of a decisional aid, integrating peer-reviewed information and preliminary data already collected from peripartum women and providers. Postpartum women who used cannabis before pregnancy will be recruited to interact with the tool and provide feedback. We will conduct qualitative data collection via semi-structured interviews soliciting feedback on the prototype to be used to improve the decisional tool.

Institution
MUSC
Recruitment Contact
Marie Hayes
843-792-9419
hayesmar@musc.edu

A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)

Date Added
November 12th, 2025
PRO Number
Pro00145701
Researcher
Erik Hansen

List of Studies

Keywords
Arthritis, Bone, Surgery
Summary

This study is designed to assess the 10-year post-surgery implant survivorship of Total Knee Arthroplasty (TKA) procedures performed using the LEGION Medial stabilized insert, which is FDA approved. Implant survivorship is defined as all of the knee-implanted components without a need for a revision. Questionnaires will be used up to 10 years after surgery to find more about the safety and performance of the device.

Institution
MUSC
Recruitment Contact
Lisa Mock
843-876-0111
mockl@musc.edu

Functional Outcomes of a Pickleball Community-Based Exercise Program for Individuals with Parkinson's Disease

Date Added
November 10th, 2025
PRO Number
Pro00148039
Researcher
Vanessa Hinson

List of Studies


Keywords
Exercise, Parkinsons
Summary

The purpose of this research is to explore the effects of participation in a pickleball community-based exercise program on function in people with Parkinson's disease (PwPD). Individuals will engage in an 8-week instructional pickleball exercise program designed specifically by Movement Disorder Specialists at the Medical University of South Carolina for PwPD. The pickleball training program involves warm-up exercises, stroke mechanics, fall safety and recovery technique training, effective movement pattern drills, game play strategies, and match play. We aim to quantify the motor function, balance, mobility, and quality of life outcomes through clinical assessments and questionnaires before and after participation in the Pick it Up Pickleball training program. This research will establish an evidence base for pickleball as a therapeutic intervention, opening the door for additional accessible and engaging exercise options for the PD community.

Institution
MUSC
Recruitment Contact
Isabelle Museck
317-478-7198
museck@musc.edu

Superiority Trial of Aphasia-focused Rehabilitation with tDCS Stimulation

Date Added
November 6th, 2025
PRO Number
Pro00147406
Researcher
Janina Wilmskoetter

List of Studies


Keywords
Language, Stroke Recovery
Summary

The purpose of this study to help us understand if adding transcranial Direct Current
Stimulation (tDCS), a non-invasive brain stimulation technique, to Speech Therapy
improves language recovery in people with Broca's aphasia and is more effective than Speech Therapy alone.

Institution
MUSC
Recruitment Contact
Stephanie Cute
843-792-7049
cute@musc.edu

Pilot Trial of Written Exposure Therapy Delivered via Telehealth to Adolescents with Posttraumatic Stress Disorder

Date Added
November 4th, 2025
PRO Number
Pro00147573
Researcher
Emily Tilstra-Ferrell

List of Studies

Keywords
Adolescents, Mental Health
Summary

Written Exposure Therapy (WET) is a five-session mental health therapy for post-traumatic stress disorder (PTSD). Research shows that it works as well as longer treatments for PTSD among people over 18, even though it requires fewer sessions than other PTSD therapies. However, WET has not been adapted and tested via telehealth with people aged 12 to 18. Our study aims to see how WET can be adapted to meet the needs of people aged 12 to 18 who have experienced trauma and currently have PTSD symptoms. To adapt WET for this age group, first we will talk with PTSD experts and people aged 12 to 18 to learn what changes might make WET more suitable for young people. We'll also deliver WET via telehealth to five people aged 12 to 18 following the manual as it is written for people over age 18 to see what needs adjusting. In the next part of the study, we will offer the adapted version of WET via telehealth to 20 people aged 12 to 18 in our MUSC integrated pediatric primary care clinic. People aged 12 to 18 will take part in five to seven weekly online therapy sessions and three virtual study visits (before therapy, after therapy, and one month later) to better understand who they are as a person and their current mental health symptoms and diagnoses. Individuals who are 18 can participate without caregiver permission; individuals aged 12 to 17 can only participate with caregiver permission. Our goal is to find the best way to provide effective PTSD treatment for young people that can be delivered in real-world pediatric primary care settings, so that ultimately more people can get the help they need after traumatic experiences.

Institution
MUSC
Recruitment Contact
Owen Winters
843-792-2615
winterso@musc.edu

A pragmatic remote approach to improve transitions of care and retention in opioid use disorder treatment.

Date Added
November 4th, 2025
PRO Number
Pro00146867
Researcher
Allison Smith

List of Studies


Keywords
Psychiatry, Substance Use
Summary

This is a small, test study to see if mailing buprenorphine works for patients with opioid use disorder and a recent medical hospitalization. It tries to remove some of the existing barriers to make it easier to stay in treatment and make it easier for individuals to keep taking their medicine after discharge. The purpose of this research study is to determine if mailing buprenorphine is possible, acceptable, and look at the early results of how well it works.

Institution
MUSC
Recruitment Contact
Hannah Schneider
843-580-8243
schneidh@musc.edu

Autism & Self-regulation: Tele-Assessment of Autonomic Psychophysiological correlates (ASAP)

Date Added
November 4th, 2025
PRO Number
Pro00146541
Researcher
Rosmary Ros-Demarize

List of Studies


Keywords
Autism, Children's Health
Summary

This study aims to evaluate the remote delivery of self-regulation assessments in young children with autism and their parents. Parents will complete online surveys. Parents and children will complete two virtual visits. At the second visit, participants will wear a heart rate monitor while completing study tasks. This study will inform research on behavioral therapies for children with autism.

Institution
MUSC
Recruitment Contact
Alexandra Marsden
843-714-1352
autismresearch@musc.edu

Multi Cancer Early Detection Biorepository

Date Added
October 29th, 2025
PRO Number
Pro00146813
Researcher
Gerard Silvestri

List of Studies


Keywords
Cancer
Summary

This study will enroll patients and collect blood samples from those who have a newly diagnosed cancer, are going to a procedure for a definitive diagnosis of cancer, or healthy control subjects. These samples that are being collected and banked will be used for future development of blood tests to detect lung cancer in future patients at the earliest stages.

Institution
MUSC
Recruitment Contact
Michael Balassone
843-792-6696
Balassom@musc.edu



-- OR --